Rebecca Bailey

Authored Items

During the COVID-19 pandemic, the use of telehealth, electronic patient portals, and other electronic modalities increased exponentially, enabling healthcare delivery while reducing patients’ and providers’ risk for SARS-CoV-2 infection.

No Link Found Between mRNA COVID-19 Vaccine and Severe Disease Flares in Patients with Rheumatic Diseases

By Rebecca Bailey

Rheumatology Practice Management December 2021 Vol 9 No 1

ACR Meeting Highlights

According to results presented at ACR Convergence 2021, the mRNA COVID-19 vaccine was not associated with severe disease flares in patients with rheumatic diseases, although certain medications that are used to treat these conditions were associated with a reduction in vaccine-induced humoral responses.

ACR Responds to 2019 Benefit and Payment Parameters Proposed Rule

By Rebecca Bailey

Rheumatology Practice Management December 2017 Vol 5 No 6

Health Policy

In a press release from November 28, 2017, the American College of Rheumatology (ACR) is urging the Centers for Medicare & Medicaid Services (CMS) to reconsider proposals reducing health exchange insurance coverage, affordability, and patient choice.

Final Report by Institute for Clinical and Economic Review Raises Concerns in the Rheumatology Community

By Rebecca Bailey

Rheumatology Practice Management June 2017 Vol 5 No 3

Health Policy

On January 20, 2017, the Institute for Clinical and Economic Review (ICER) released a Draft Evidence Report evaluating the clinical effectiveness and relative value—including value-based price benchmarks—of targeted immune modulators used to treat patients with moderate-to-severe rheumatoid arthritis (RA).

Institute for Clinical and Economic Review Releases Draft Report on Therapies for Rheumatoid Arthritis

By Rebecca Bailey

Rheumatology Practice Management February 2017 Vol 5 No 1

ICER News

On March 24, 2017, this report will be the topic of a free, public meeting held by the New England Comparative Effectiveness Public Advisory Council, a nationally recognized community forum and core program of Institute for Clinical and Economic Review, in Boston, MA. During this meeting, recommendations that can be translated to policy and practice in the field of rheumatology will be deliberated by an expert policy roundtable, and the New England Comparative Effectiveness Public Advisory Council will vote on important questions brought up in the Draft Evidence Report.

How to Prepare for MACRA

By Rebecca Bailey

Rheumatology Practice Management December 2016 Vol 4 No 6

Conference News

Last fall, the Centers for Medicare & Medicaid Services (CMS) released its final rule implementing the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). The final rule provides Medicare incentives to reward quality and value—not volume—through the use of alternative payment models.

Challenges and Opportunities in the Era of Biosimilar Therapy

By Rebecca Bailey

Rheumatology Practice Management December 2016 Vol 4 No 6

Conference News

Washington, DC—The use of biosimilars offers great potential to reduce healthcare spending while expanding access to effective therapies for conditions such as rheumatoid arthritis. The numerous issues related to the development, regulation, reimbursement, and marketing of these agents were addressed by Candida Fratazzi, MD, President, BBCR Consulting, Cambridge, MA, at the 2016 Annual Meeting of the American College of Rheumatology.

Rebecca Bailey

Authored Items

December 2021, Vol 9, No 1